Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Compensatie door gezonde hersendelen verlicht klachten bij Parkinson
nov 2023 | Bewegingsstoornissen